Human CCL17/A-152E5.3/ABCD-2 ORF/cDNA clone-Lentivirus plasmid (NM_002987)
Cat. No.: pGMLP004761
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human CCL17/A-152E5.3/ABCD-2 Lentiviral expression plasmid for CCL17 lentivirus packaging, CCL17 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
CCL17/A-152E5.3 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLP004761 |
Gene Name | CCL17 |
Accession Number | NM_002987 |
Gene ID | 6361 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 285 bp |
Gene Alias | A-152E5.3,ABCD-2,SCYA17,TARC |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCCCCACTGAAGATGCTGGCCCTGGTCACCCTCCTCCTGGGGGCTTCTCTGCAGCACATCCACGCAGCTCGAGGGACCAATGTGGGCCGGGAGTGCTGCCTGGAGTACTTCAAGGGAGCCATTCCCCTTAGAAAGCTGAAGACGTGGTACCAGACATCTGAGGACTGCTCCAGGGATGCCATCGTTTTTGTAACTGTGCAGGGCAGGGCCATCTGTTCGGACCCCAACAACAAGAGAGTGAAGAATGCAGTTAAATACCTGCAAAGCCTTGAGAGGTCTTGA |
ORF Protein Sequence | MAPLKMLALVTLLLGASLQHIHAARGTNVGRECCLEYFKGAIPLRKLKTWYQTSEDCSRDAIVFVTVQGRAICSDPNNKRVKNAVKYLQSLERS |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-SE0742-Ab | Anti-CCL17/ A-152E5.3/ ABCD-2 functional antibody |
Target Antigen | GM-Tg-g-SE0742-Ag | CCL17 protein |
Cytokine | cks-Tg-g-GM-SE0742 | chemokine (C-C motif) ligand 17 (CCL17) protein & antibody |
ORF Viral Vector | pGMLP004761 | Human CCL17 Lentivirus plasmid |
ORF Viral Vector | vGMLP004761 | Human CCL17 Lentivirus particle |
Target information
Target ID | GM-SE0742 |
Target Name | CCL17 |
Gene Group Identifier (Target Gene ID in Homo species) |
6361 |
Gene ID |
100140488 (Bos taurus), 100630824 (Equus caballus), 117518 (Rattus norvegicus), 20295 (Mus musculus) 403586 (Canis lupus familiaris), 493832 (Felis catus), 574180 (Macaca mulatta), 6361 (Homo sapiens) |
Gene Symbols & Synonyms | CCL17,Ccl17,Tarc,Scya17,Abcd-2,Scya17l,TARC,ABCD-2,SCYA17,A-152E5.3 |
Target Alternative Names | CCL17,C-C motif chemokine 17,CC chemokine TARC, Small-inducible cytokine A17, Thymus and activation-regulated chemokine,TARC,ABCD-2,SCYA17,A-152E5.3 |
Uniprot Accession |
Q8HYP9,Q8I021,Q92583,Q95N01,Q9ERE0,Q9WUZ6
Additional SwissProt Accessions: Q9ERE0,Q9WUZ6,Q95N01,Q8I021,Q8HYP9,Q92583 |
Uniprot Entry Name | |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Cytokine Target |
Disease | cancer, Breast Cancer, Overactive bladder |
Disease from KEGG | Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, Chemokine signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway |
Gene Ensembl | ENSBTAG00000066638, ENSMUSG00000031780, ENSCAFG00845003329, ENSMMUG00000058419, ENSG00000102970 |
Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.